421 related articles for article (PubMed ID: 28802714)
1. In silico structure-based approaches to discover protein-protein interaction-targeting drugs.
Shin WH; Christoffer CW; Kihara D
Methods; 2017 Dec; 131():22-32. PubMed ID: 28802714
[TBL] [Abstract][Full Text] [Related]
2. AlphaSpace: Fragment-Centric Topographical Mapping To Target Protein-Protein Interaction Interfaces.
Rooklin D; Wang C; Katigbak J; Arora PS; Zhang Y
J Chem Inf Model; 2015 Aug; 55(8):1585-99. PubMed ID: 26225450
[TBL] [Abstract][Full Text] [Related]
3. Targeting protein-protein interactions and fragment-based drug discovery.
Valkov E; Sharpe T; Marsh M; Greive S; Hyvönen M
Top Curr Chem; 2012; 317():145-79. PubMed ID: 22006238
[TBL] [Abstract][Full Text] [Related]
4. Fast Rescoring Protocols to Improve the Performance of Structure-Based Virtual Screening Performed on Protein-Protein Interfaces.
Singh N; Chaput L; Villoutreix BO
J Chem Inf Model; 2020 Aug; 60(8):3910-3934. PubMed ID: 32786511
[TBL] [Abstract][Full Text] [Related]
5. Benchmark Study Based on 2P2I
Wang Z; Kang Y; Li D; Sun H; Dong X; Yao X; Xu L; Chang S; Li Y; Hou T
J Phys Chem B; 2018 Mar; 122(9):2544-2555. PubMed ID: 29420886
[TBL] [Abstract][Full Text] [Related]
6. Improving small molecule virtual screening strategies for the next generation of therapeutics.
Wingert BM; Camacho CJ
Curr Opin Chem Biol; 2018 Jun; 44():87-92. PubMed ID: 29920436
[TBL] [Abstract][Full Text] [Related]
7. Surfing the Protein-Protein Interaction Surface Using Docking Methods: Application to the Design of PPI Inhibitors.
Sable R; Jois S
Molecules; 2015 Jun; 20(6):11569-603. PubMed ID: 26111183
[TBL] [Abstract][Full Text] [Related]
8. Network analysis and in silico prediction of protein-protein interactions with applications in drug discovery.
Murakami Y; Tripathi LP; Prathipati P; Mizuguchi K
Curr Opin Struct Biol; 2017 Jun; 44():134-142. PubMed ID: 28364585
[TBL] [Abstract][Full Text] [Related]
9. In Silico Target Druggability Assessment: From Structural to Systemic Approaches.
Trosset JY; Cavé C
Methods Mol Biol; 2019; 1953():63-88. PubMed ID: 30912016
[TBL] [Abstract][Full Text] [Related]
10. A novel small-molecule PPI inhibitor targeting integrin αvβ3-osteopontin interface blocks bone resorption in vitro and prevents bone loss in mice.
Park D; Park CW; Choi Y; Lin J; Seo DH; Kim HS; Lee SY; Kang IC
Biomaterials; 2016 Aug; 98():131-42. PubMed ID: 27187277
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel inhibitors of Keap1/Nrf2 by a promising method combining protein-protein interaction-oriented library and machine learning.
Shimizu Y; Yonezawa T; Sakamoto J; Furuya T; Osawa M; Ikeda K
Sci Rep; 2021 Apr; 11(1):7420. PubMed ID: 33795749
[TBL] [Abstract][Full Text] [Related]
12. Natural products used as a chemical library for protein-protein interaction targeted drug discovery.
Jin X; Lee K; Kim NH; Kim HS; Yook JI; Choi J; No KT
J Mol Graph Model; 2018 Jan; 79():46-58. PubMed ID: 29136547
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design of small-molecule protein-protein interaction modulators: the story so far.
Falchi F; Caporuscio F; Recanatini M
Future Med Chem; 2014 Mar; 6(3):343-57. PubMed ID: 24575969
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area.
Ran X; Gestwicki JE
Curr Opin Chem Biol; 2018 Jun; 44():75-86. PubMed ID: 29908451
[TBL] [Abstract][Full Text] [Related]
15. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
Thiel P; Kaiser M; Ottmann C
Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
[TBL] [Abstract][Full Text] [Related]
16. Evaluating protein-protein interaction (PPI) networks for diseases pathway, target discovery, and drug-design using 'in silico pharmacology'.
Chakraborty C; Doss C GP; Chen L; Zhu H
Curr Protein Pept Sci; 2014; 15(6):561-71. PubMed ID: 25059326
[TBL] [Abstract][Full Text] [Related]
17. Protein-protein interactions: network analysis and applications in drug discovery.
Bultinck J; Lievens S; Tavernier J
Curr Pharm Des; 2012; 18(30):4619-29. PubMed ID: 22650261
[TBL] [Abstract][Full Text] [Related]
18. Challenges in Discovering Drugs That Target the Protein-Protein Interactions of Disordered Proteins.
Oláh J; Szénási T; Lehotzky A; Norris V; Ovádi J
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163473
[TBL] [Abstract][Full Text] [Related]
19. Function and structure-based screening of compounds, peptides and proteins to identify drug candidates.
Malik V; Dhanjal JK; Kumari A; Radhakrishnan N; Singh K; Sundar D
Methods; 2017 Dec; 131():10-21. PubMed ID: 28843611
[TBL] [Abstract][Full Text] [Related]
20. Methods for Discovering and Targeting Druggable Protein-Protein Interfaces and Their Application to Repurposing.
Ozdemir ES; Halakou F; Nussinov R; Gursoy A; Keskin O
Methods Mol Biol; 2019; 1903():1-21. PubMed ID: 30547433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
